One-year clinical outcomes with SAPIEN 3 transcatheter aortic valve replacement in high risk and inoperable patients with severe aortic stenosis

July 12, 2016

DALLAS, July 12, 2016 --Overall one-year survival was over 85 percent for high-risk or inoperable patients who underwent aortic valve replacement with the SAPIEN 3 trans-catheter aortic valve replacement system, according to a study published in the July 12 issue of the American Heart Association journal Circulation. This survival rate is strikingly higher compared to patient outcomes reported in studies that used older trans-catheter aortic valve replacements (TAVR) systems.

Between 30 days and one year, there was no increase in the low rate of moderate leaking around the prosthetic valve, which had been observed in earlier studies, and patients experienced a marked improvement in the quality of life.

This study suggests that the SAPIEN 3 system might be the preferred therapy for high-risk and inoperable patients with aortic stenosis. The authors also conclude that the system should receive additional evaluation to see if it would be appropriate for lower-risk patients.

Limitations: This study is a prospective registry of the Partner II trial of transcatheter aortic valve replacement (TAVR) for high risk (HR) and inoperable (INOP) patients, and was not a randomized comparison to other devices or patient populations. Therefore, such comparisons should be considered exploratory.

Funding Sources: The PARTNER Trial was funded by Edwards Lifesciences and the protocol was designed collaboratively by the sponsor and the trial executive committee. The sponsor was involved in data collection and management, but was not involved in the design and conduct of this substudy, the analysis and interpretation of the data, or the preparation, review, and approval of the manuscript.
-end-
Study author: Howard C. Herrmann, M.D., John Bryfogle professor of Cardiovascular Medicine and Surgery at the Perelman School of Medicine of the University of Pennsylvania and System Director for Interventional Cardiology and Director of the Cardiac Catheterization Laboratories, Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania.

Additional Resources:

Heart graphic is located in the right column of this release link http://newsroom.heart.org/news/one-year-clinical-outcomes-with-sapien-3-transcatheter-aortic-valve-replacement-in-high-risk-and-inoperable-patients-with-severe-aortic-stenosis?preview=fc924660c161f163be5a1e93e457e7b1

Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association's policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at http://www.heart.org/corporatefunding.

American Heart Association

Related Aortic Stenosis Articles from Brightsurf:

Aortic valve replacement during COVID-19 pandemic
The outcomes associated with deferred compared with expedited aortic valve replacement in patients with severe aortic stenosis during the COVID-19 pandemic are evaluated in this observational study.

Patients deferred for transcatheter aortic valve replacement because of COVID-19
This single-center study of 77 patients describes the outcomes of patients with symptomatic severe aortic stenosis during the COVID-19 pandemic.

External ultrasound therapy of calcific aortic stenosis -- First-in-man
Cardiawave (France) has developed a Non-Invasive Ultrasound Therapy (NIUT) for the treatment of cardio-valvular diseases such as aortic stenosis.

Cutting-edge imaging may provide insight into the functional significance of a stenosis
A novel study aims to evaluate whether optical coherence tomography (OCT) parameters may predict fractional flow reserve (FFR) values and assess if OCT parameters may predict clinical outcome in patients with negative FFR.

Management and outcomes of aortic dissection in pregnancy with Marfan Syndrome
In Marfan Syndrome (MFS), aortic dilatation is one of the main cardiovascular manifestations which deteriorate due to the physiological changes during pregnancy.

Researchers uncover new cause of abdominal aortic aneurysm
Researchers have discovered that a family of lipids (fats) contribute to the development of a serious aortic disease, by driving clotting in the blood vessel wall.

Early valve replacement versus watchful waiting in patients with severe aortic stenosis
Patients with severe aortic stenosis who have no symptoms may benefit more from an aggressive strategy of early valve replacement than from a conservative watch-and-wait approach, according to new research published today online in The Annals of Thoracic Surgery.

Registry helps move aortic dissection care forward
Diagnosis, treatments and outcomes for acute aortic dissection have evolved.

In study, TAVR is superior to surgery for low-risk patients with aortic valve stenosis
A large clinical trial has found that a minimally invasive procedure to replace a narrowed heart valve performed better than surgery in patients who were good candidates for surgery.

Women more likely to have poorer outcomes following aortic surgery
New research says women fare worse than men following aortic heart surgery.

Read More: Aortic Stenosis News and Aortic Stenosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.